A group of clinicians and patients has called on the government at Holyrood to adopt a “Scotland-wide focus” on chronic kidney disease (CKD), saying that as many as 600,000 Scots are now thought to be ...

AstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance ...

Analyst Etzer Darout of BMO Capital maintained a Buy rating on AstraZeneca (AZN – Research Report), retaining the price target of $89.00.

AstraZeneca (GB:AZN) has released an update. AstraZeneca remains committed to delivering its innovative medicines in China despite ongoing ...

AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior ...

While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb ...

Mankia received grant support from Gilead, Lilly, AstraZeneca, and Serac Life Sciences and honoraria or consultant fees from AbbVie, UCB, Lilly, Galapagos, DeepCure, Serac Life Sciences, AstraZeneca, ...

Anaheim Ducks forward Alex Killorn heaped praise on teammate Leo Carlsson as he says he surprises him everyday with how good ...

Amgen ( AMGN 1.68%), a leader in biotechnology, released its third-quarter 2024 financial results on Oct. 30. The company ...

In a frothy market starved for value, these three dividend stocks combine reasonable valuations with the proven ability to ...